| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | N9-isopropylolomoucine | CTRPv2 | pan-cancer | AAC | 0.055 | 0.1 |
| mRNA | Compound 1541A | CTRPv2 | pan-cancer | AAC | 0.059 | 0.1 |
| mRNA | fluvastatin | CTRPv2 | pan-cancer | AAC | -0.055 | 0.1 |
| mRNA | PDMP | CTRPv2 | pan-cancer | AAC | 0.057 | 0.1 |
| mRNA | myriocin | CTRPv2 | pan-cancer | AAC | -0.11 | 0.1 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.078 | 0.1 |
| mRNA | lapatinib | CTRPv2 | pan-cancer | AAC | 0.053 | 0.1 |
| mRNA | vorinostat:carboplatin (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.051 | 0.1 |
| mRNA | piperlongumine | CTRPv2 | pan-cancer | AAC | 0.048 | 0.1 |
| mRNA | BRD-K96970199 | CTRPv2 | pan-cancer | AAC | 0.11 | 0.1 |